Want to see GB:GNIP full AI Analyst Report?
Top Page
GenIP Plc
(LSE:GNIP)
Select Model
Select Model
Rating:41Neutral
Price Target:
2.50 p
▼(-10.71% Downside)
Action:Reiterated
Date:08/29/26
The score is held down primarily by continued heavy losses and ongoing negative free cash flow despite improved revenue and gross margin. Technicals also remain weak with the stock trading below all major moving averages and a negative MACD, while valuation metrics provided do not offer clear support (P/E shown as 0.000 and no dividend yield).
Positive Factors
Strong revenue acceleration
The sharp increase in revenue indicates improved commercial traction and broader customer adoption. Sustaining this growth would provide greater operating leverage and create a stronger base for eventual profitability, although execution remains important.
Negative Factors
Persistent heavy losses
The company has not yet demonstrated a viable path to sustainable profitability. Continued large operating and net losses can consume resources, restrict investment capacity, and increase dependence on future financing or further business improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue acceleration
The sharp increase in revenue indicates improved commercial traction and broader customer adoption. Sustaining this growth would provide greater operating leverage and create a stronger base for eventual profitability, although execution remains important.
Read all positive factors
GenIP Plc (GNIP) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£676.21K
Dividend YieldN/A
Average Volume (3M)66.32K
Price to Earnings (P/E)―
Beta (1Y)1.48
Revenue GrowthN/A
EPS GrowthN/A
CountryUK
Employees2
SectorGeneral
Sector StrengthN/A
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)-0.01
Shares Outstanding25,517,462
10 Day Avg. Volume61,054
30 Day Avg. Volume66,322
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GenIP Plc Business Overview & Revenue Model
Company Description
GenIP Plc specializes in developing pioneering generative artificial intelligence solutions. The company was founded on February 23, 2024, and its primary operations are situated in London, United Kingdom....
GenIP Plc Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
56
Neutral
Cash Flow
34
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 0.00 | 520.39K | 123.02K |
| Gross Profit | 0.00 | 164.74K | 15.16K |
| EBITDA | -93.41K | -1.06M | -832.54K |
| Net Income | -93.56K | -1.25M | -886.83K |
Balance Sheet | |||
| Total Assets | 307.59K | 1.05M | 1.63M |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 660.99K | 972.36K |
| Total Debt | 72.14K | 0.00 | 133.57K |
| Total Liabilities | 145.66K | 470.42K | 359.74K |
| Stockholders Equity | 161.93K | 579.16K | 1.27M |
Cash Flow | |||
| Free Cash Flow | -71.98K | -736.00K | -683.04K |
| Operating Cash Flow | -69.91K | -720.31K | -556.74K |
| Investing Cash Flow | -2.07K | -6.07K | -124.49K |
| Financing Cash Flow | 71.98K | 415.01K | 1.65M |
GenIP Plc Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | £69.16M | 20.14 | 18.91% | ― | -3.15% | -17.89% | |
59 Neutral | £34.17M | -105.71 | -1.32% | 0.04% | -41.95% | -106.40% | |
57 Neutral | £364.51M | -4.95 | -14.39% | 2.76% | 0.82% | -997.08% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | £32.54M | -4.28 | -21.57% | 12.50% | 4.57% | -3.85% | |
41 Neutral | £676.21K | ― | -135.15% | ― | ― | ― |
* General Sector Average
GB:GNIP
GenIP Plc
2.65
-17.85
-87.07%
GB:PULS
Access Intelligence
24.00
-14.00
-36.84%
GB:CLBS
Celebrus Technologies
91.50
-64.84
-41.47%
GB:GBG
GB Group plc
159.40
-50.50
-24.06%
GB:IGP
Intercede
114.00
-56.00
-32.94%
GenIP Plc Corporate Events
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
GenIP Deepens Global Footprint as Losses Widen on Early-Stage Investment
Positive
Aug 28, 2026
GenIP reported unaudited interim results for the first half of 2026 showing modest revenue of $53,000, a 6% gross margin and an adjusted EBITDA loss of $692,000, with $410,000 in cash at period end, as the company continues to invest heavily from ...
Business Operations and StrategyFinancial Disclosures
GenIP Secures New Global Contracts and Expands AI-Driven Innovation Services
Positive
Aug 11, 2026
GenIP Plc has secured a series of new and recurring contracts worth a total of $87,000 across Chile, the UK and North America, driven primarily by demand for its Invention Evaluator reports from leading research universities. The company has deepe...
Business Operations and StrategyProduct-Related AnnouncementsShareholder Meetings
GenIP Steps Up Global Expansion as AI‑Driven SaaS Platform Nears Launch
Positive
Jun 30, 2026
GenIP has outlined its next phase of growth following the CEO’s recent visit to the U.K. for its AGM and a series of meetings with clients, investors and strategic partners. The company hosted an AI‑focused roundtable with leaders from...
Business Operations and StrategyShareholder Meetings
GenIP Wins Strong Shareholder Backing at AGM, Securing Mandates for Growth
Positive
Jun 24, 2026
GenIP Plc said all resolutions at its annual general meeting were passed, including approval of its annual report, reappointment of auditor HW Fisher LLP, and the re-election of key board members such as Lord David Willetts, Melissa Cruz, Kevin Fi...
Business Operations and Strategy
GenIP strengthens AI-led tech transfer position with high-level UK roundtable
Positive
Jun 24, 2026
GenIP Plc has underlined its role in AI-driven technology transfer by hosting a closed-door senior roundtable with Knowledge Exchange UK, attended by more than twenty high-level figures from universities, government, research agencies and internat...
Regulatory Filings and Compliance
GenIP Updates Total Voting Rights and Share Capital Structure
Neutral
May 29, 2026
GenIP Plc has confirmed that its total issued share capital consists of 25,517,461 ordinary shares of £0.00425 each, all carrying voting rights, and that it holds no shares in treasury. This updated share capital figure provides investors wit...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.